Trial Profile
A Randomized, Single-Blind, Controlled, Monocentric Phase II Trial to Compare the Safety and Neutralizing Activity of Simulated Rabies Post-Exposure Prophylaxis With CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2011
Price :
$35
*
At a glance
- Drugs Foravirumab (Primary) ; Rabies immune globulin; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions
- Sponsors Crucell
- 08 Apr 2008 New trial record.